Retreatment with cabazitaxel in a long-surviving patient with castration-resistant prostate cancer and visceral metastasis

Retreatment with cabazitaxel in a long-surviving patient with castration-resistant prostate cancer and visceral metastasis

Prostate tumors are the most frequent malignant cancer among men. In recent years, we have seen a significant progress in the knowledge of the carcinogenesis of prostate cancer, leading to the development of effective drugs in this scenario. Prostate cancer patients had no effective therapeutic alte...

Full description

Bibliographic Details
Main Authors: Raquel Luque Caro, Carmen Sánchez Toro, Lucia Ochoa Vallejo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Cancer Translational Medicine
Subjects:
Cabazitaxel rechallenge
castration resistant
prostate cancer
Online Access:http://www.cancertm.com/article.asp?issn=2395-3977;year=2018;volume=4;issue=3;spage=83;epage=88;aulast=Luque

Internet

http://www.cancertm.com/article.asp?issn=2395-3977;year=2018;volume=4;issue=3;spage=83;epage=88;aulast=Luque

Similar Items